evaluate the pharmaceuticals company rybelsus on glp-1 and insurance providers Market Industry Trends Global Forecasts Insurance coverage just changed for

Dont miss Food Navigators broadcast series on Weight Management Join industry leaders and scientists on November 13 & 19 as we explore how the rise of GLP-1 weight-loss drugs is disrupting the food & beverage space and uncover how functional foods, bioactive ingredients and next-gen formulations can reshape satiety, metabolism and brand opportunity

& Almeida, D

Tesamorelin is a stabilized GHRH analog with an N-terminal modification that resists enzymatic breakdown, producing a longer functional duration and more consistent effects

The growing influence of GLP-1 therapies may be a catalyst for some of those shifts